Skip to main content Accessibility help

Chromium and insulin resistance

  • Richard A. Anderson (a1)


Insulin resistance leads to the inability of insulin to control the utilization and storage of glucose. It is associated initially with elevated levels of circulating insulin followed by glucose intolerance which may progress to type 2 diabetes, hyperlipidaemia, hypertension, obesity and cardiovascular diseases. While the causes of these diseases are multifactorial, one nutrient that is associated with all of these abnormalities is Cr. In the presence of Cr, in a biologically active form, much lower levels of insulin are required. Modern diets, which are often high in refined carbohydrates, are not only low in Cr, but lead to enhanced Cr losses. In response to the consumption of refined carbohydrates, there is a rapid rise in blood sugar leading to elevations in insulin that cause a mobilization of Cr. Once mobilized, Cr is not reabsorbed but lost via the urine leading to decreased Cr stores. Several studies involving both human subjects and experimental animals have reported improvements in insulin sensitivity, blood glucose, insulin, lipids, haemoglobin A1c, lean body mass and related variables in response to improved Cr nutrition. However, not all studies have reported beneficial effects associated with improved Cr nutrition. Well–controlled human studies are needed to document an unequivocal effect of Cr on insulin sensitivity in human subjects. Studies need to involve a significant number of subjects with insulin resistance, glucose intolerance or early stages of diabetes, who have not been taking supplements containing Cr for at least 4 months, and involve at least 400 to 600 μg supplemental Cr daily or more. Studies should be at least 4 months to document sustained effects of supplemental Cr on insulin resistance and related variables. Cr is a nutrient and not a therapeutic agent and therefore will only be of benefit to those whose problems are due to suboptimal intake of Cr.

    • Send article to Kindle

      To send this article to your Kindle, first ensure is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

      Note you can select to send to either the or variations. ‘’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

      Find out more about the Kindle Personal Document Service.

      Chromium and insulin resistance
      Available formats

      Send article to Dropbox

      To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

      Chromium and insulin resistance
      Available formats

      Send article to Google Drive

      To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

      Chromium and insulin resistance
      Available formats


Corresponding author

Corresponding author: Dr Richard A. Anderson, fax +1 301 504 9062, email


Hide All
Abraham, AS, Brooks, BA & Eylath, U (1992) The effects of chromium supplementation on serum glucose and lipids in patients with and without non–insulin–dependent diabetes. Metabolism 41, 768771.
Althuis, MD, Jordan, NE, Ludington, EA & Wittes, JT (2002) Glucose and insulin responses to dietary chromium supplements: a meta–analysis. American Journal of Clinical Nutrition 76, 148155.
Anderson, RA (1994) Stress effects on chromium nutrition of humans and farm animals. In Proceedings of Alltech's Tenth Symposium on Biotechnology in the Feed Industry, pp.267274 [TP Lyons and KA Jacques editors]. Nottingham, UK: University Press.
Anderson, RA (1997) Chromium as an essential nutrient for humans. Regulatory Toxicology and Pharmacology 26, S35–S41.
Anderson, RA (1998a) Chromium, glucose intolerance and diabetes. Journal of the American College of Nutrition 17, 548555.
Anderson, RA (1998b) Effects of chromium on body composition and weight loss. Nutrition Reviews 56, 266270.
Anderson, RA (2002) Insulin, glucose intolerance and diabetes: Recent data regarding the chromium connection. Trace Elements Nutritional Health and Disease Proceedings 1, 7986.
Anderson, RA, Bryden, NA & Polansky, MM (1997a) Lack of toxicity of chromium chloride and chromium picolinate in rats. Journal of the American College of Nutrition 16, 273279.
Anderson, RA, Bryden, NA, Polansky, MM & Thorp, JW (1991) Effect of carbohydrate loading and underwater exercise on circulating cortisol, insulin and urinary losses of chromium and zinc. European Journal of Applied Physiology 63, 146150.
Anderson, RA, Cheng, N, Bryden, NA, Polansky, MM, Chi, J & Feng, J (1997b) Elevated intakes of supplemental chromium improve glucose and insulin variables in individuals with type 2 diabetes. Diabetes 46, 17861791.
Anderson, RA & Kozlovsky, AS (1985) Chromium intake, absorption and excretion of subjects consuming self–selected diets. American Journal of Clinical Nutrition 41, 11771183.
Anderson, RA, Polansky, MM, Bryden, NA, Bhathena, SJ & Canary, JJ (1987) Effects of supplemental chromium on patients with symptoms of reactive hypoglycemia. Metabolism 36, 351355.
Anderson, RA, Polansky, MM, Bryden, NA & Canary, JJ (1991) Supplemental–chromium effects on glucose, insulin, glucagon, and urinary chromium losses in subjects consuming controlled low–chromium diets. American Journal of Clinical Nutrition 54, 909916.
Anderson, RA, Polansky, MM, Bryden, NA, Roginski, EE, Patterson, KY & Reamer, DC (1982) Effect of exercise (running) on serum glucose, insulin, glucagon, and chromium excretion. Diabetes 31, 212216.
Anderson, RA, Roussel, AM, Zouari, N, Mahjoub, S, Matheau, JM & Kerkeni, A (2001) Potential antioxidant effects of zinc and chromium supplementation in people with type 2 diabetes mellitus. Journal of the American College of Nutrition 20, 212218.
Borel, JS, Majerus, TC, Polansky, MM, Moser, PB & Anderson, RA (1984) Chromium intake and urinary chromium excretion of trauma patients. Biological Trace Element Research 6, 317326.
Brock, JH (1985) Transferrins. In Metalloenzymes, vol.2, pp.183262 [PM Harrison editor]. London, UK: MacMillan.
Cefalu, WT, Bell-Farrow, AD, Stegners, J, Wang, ZQ, King, T, Morgan, T & Terry, JG (1999) Effect of chromium picolinate on insulin sensitivity in vivo. Journal of Trace Elements in Experimental Medicine 12, 7184.
Cefalu, WT, Wang, ZQ, Zhang, XH, Baldor, LC & Russell, JC (2002) Oral chromium picolinate improves carbohydrate and lipid metabolism and enhances skeletal muscle Glut–4 translocation in obese, hyperinsulinemic (JCR–LA corpulent) rats. Journal of Nutrition 132, 11071114.
Chang, X & Mowat, DN (1992) Supplemental chromium for stressed and growing feeder calves. Journal of Animal Science 70, 559565.
Davies, S, McLaren, HJ, Hunnisett, A & Howard, M (1997) Age–related decreases in chromium levels in 51,665 hair, sweat, and serum samples from 40,872 patients – implications for the prevention of cardiovascular disease and type II diabetes mellitus. Metabolism 46, 469473.
Davis, CM, Sumrall, KH & Vincent, JB (1996) A biologically active form of chromium may activate a membrane phosphotyrosine phosphatase (PTP). Biochemistry 35, 1296312969.
Davis, CM & Vincent, JB (1997) Chromium oligopeptide activates insulin receptor kinase activity. Biochemistry 36, 43824385.
Doisy, RJ, Streeten, DHP, Souma, DHP, Kalafer, ME, Rekant, SL & Dalakos, TG (1971) Metabolism of chromium 51 in human subjects. In Newer Trace Elements in Nutrition, pp.155168 [W Mertz and WE Cornatzer editors]. New York, NY: Marcel Dekker.
Ekstrand, AV, Eriksson, JG, Gronhagen-Riska, C, Ahonen, PJ & Groop, LC (1992) Insulin resistance and insulin deficiency in the pathogenesis of posttransplantation diabetes in man. Transplantation 53, 563569.
Evock-Clover, CM, Polansky, MM, Anderson, RA & Steele, NC (1993) Dietary chromium supplementation with or without somatotropin treatment alters serum hormones and metabolites in growing pigs without affecting growth performance. Journal of Nutrition 123, 15041512.
Faul, JL, Tormey, W, Tormey, V & Burke, C (1998) High dose inhaled corticosteroids and dose dependent loss of diabetic control. British Medical Journal 317, 1491.
Institute of Medicine Staff (2001) Dietary Reference Intakes for VitaminA, Vitamin|K, Arsenic, Boron, Chromium, Copper, Iodine, Iron, Manganese, Molybdenum, Nickel, Silicon, Vanadium, and Zinc, pp.197223. Washington, DC: National Academy Press.
Jain, SK & Kannan, K (2001) Chromium chloride inhibits oxidative stress and TNF–alpha secretion caused by exposure to high glucose in cultured U937 monocytes. Biochemical and Biophysical Research Communications 289, 687691.
Jovanovic, L, Gutierrez, M & Peterson, CM (1999) Chromium supplementation for women with gestational diabetes mellitus. Journal of Trace Elements in Experimental Medicine 12, 9198.
Kaats, GR, Blum, K, Fisher, JA & Adelman, JA (1996) Effects of chromium picolinate supplementation on body composition: a randomized double–masked placebo–controlled study. Current Therapeutic Research 57, 747756.
Kandror, KV (1999) Insulin regulation of protein traffic in rat adipose cells. Journal of Biological Chemistry 274, 2521025217.
Kern, PA, Ranganathan, S, Li, C, Wood, L & Ranganathan, G (2001) Adipose tissue tumor necrosis factor and interleukin–6 expression in human obesity and insulin resistance. American Journal of Physiology 280, E745–E751.
Kim, DS, Kim, TW, Park, IK, Kang, JS & Om, AS (2002) Effects of chromium picolinate supplementation on insulin sensitivity, serum lipids, and body weight in dexamethasone–treated rats. Metabolism 51, 589594.
Kozlovsky, AS, Moser, PB, Reiser, S & Anderson, RA (1986) Effects of diets high in simple sugars on urinary chromium losses. Metabolism 35, 515518.
Kraegen, EW, Cooney, GJ, Ye, J & Thompson, AL (2001) Triglycerides, fatty acids and insulin resistance – hyperinsulinemia. Experimental and Clinical Endocrinology and Diabetes 109, S516–S526.
Lopez-Candales, A (2001) Metabolic syndrome X: a comprehensive review of the pathophysiology and recommended therapy. Journal of Medicine 32, 283300.
Mandali, SL, Stoecker, BJ, Maxwell, CV, de Rodas, BZ & Arquitt, AB (2002) Endotoxin decreases 51CrCl3 uptake in early weaned pigs. Biological Trace Element Research 88, 145151.
Mertz, W, Abernathy, CO & Olin, SS (1994) Risk Assessment of Essential Elements. Washington, DC: ILSI Press.
Morris, BW (1999) Chromium action and glucose homeostasis. Journal of Trace Elements in Experimental Medicine 12, 6170.
Morris, BW, Blumsohn, A, MacNeil, S & Gray, TA (1992) The trace element chromium – a role in glucose homeostasis. American Journal of Clinical Nutrition 55, 989991.
Morris, BW, MacNeil, S, Hardisty, CA, Heller, S, Burgin, C & Gray, TA (1999) Chromium homeostasis in patients with type II (NIDDM) diabetes. Journal of Trace Elements in Experimental Medicine 13, 5761.
Morris, BW, Samaniego, S, Fraser, R & MacNeil, S (2000) Increased chromium excretion in pregnancy is associated with insulin resistance. Journal of Trace Elements in Experimental Medicine 13, 389396.
Pagano, G, Bruno, A, Cavallo-Perin, P, Cesco, L & Imbimbo, B (1989) Glucose intolerance after short-term administration of corticosteroids in healthy subjects. Prednisone, deflazacort, and betamethasone. Archives of Internal Medicine 149, 10981101.
Ravina, A, Slezak, L, Mirsky, N & Anderson, RA (1999a) Control of steroid-induced diabetes with supplemental chromium. Journal of Trace Elements in Experimental Medicine 12, 375378.
Ravina, A, Slezak, L, Mirsky, N, Bryden, NA & Anderson, RA (1999b) Reversal of corticosteroid–induced diabetes mellitus with supplemental chromium. Diabetic Medicine 16, 164167.
Rubin, MA, Miller, JP, Ryan, AS, Treuth, MS, Patterson, KY, Pratley, PE, Hurley, BF, Veillon, C, Moser-Veillon, P & Anderson, RA (1998) Acute and chronic resistive exercise increase urinary chromium excretion in men as measured with an enriched chromium stable isotope. Journal of Nutrition 128, 7378.
Stojanovska, L, Rosella, G & Proietto, J (1990) Evolution of dexamethasone–induced insulin resistance in rats. American Journal of Physiology 258, E748–E756.
Striffler, JS, Polansky, MM & Anderson, RA (1998) Dietary chromium decreases insulin resistance in rats fed a high-fat, mineral–imbalanced diet. Metabolism 47, 396400.
Striffler, JS, Polansky, MM & Anderson, RA (1999) Overproduction of insulin in the chromium-deficient rat. Metabolism 48, 10631068.
Sun, Y, Ramirez, J, Woski, SA & Vincent, JB (2000) The binding of trivalent chromium to low-molecular-weight chromium-binding substance (LMWCr) and the transfer of chromium from transferrin and chromium picolinate to LMWCr. Journal of Biological Inorganic Chemistry 5, 129136.
Tuman, RW & Doisy, RJ (1977) Metabolic effects of the glucose tolerance factor (GTF) in normal and genetically diabetic mice. Diabetes 26, 820826.
Vincent, JB (2000) The biochemistry of chromium. Journal of Nutrition 130, 715718.
Yamamoto, A, Wada, O & Suzuki, H (1988) Purification and properties of biologically active chromium complex from bovine colostrum. Journal of Nutrition 118, 3945.


Related content

Powered by UNSILO

Chromium and insulin resistance

  • Richard A. Anderson (a1)


Altmetric attention score

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed.